4
|
Deng Y, Wang L, Sun X, Liu L, Zhu M, Wang C, Sui B, Shen M, Gu W, Mo D, Ma N, Song L, Li X, Huo X, Miao Z, Chen D, Gao F. Association Between Cerebral Hypoperfusion and Cognitive Impairment in Patients With Chronic Vertebra-Basilar Stenosis. Front Psychiatry 2018; 9:455. [PMID: 30319462 PMCID: PMC6168951 DOI: 10.3389/fpsyt.2018.00455] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Accepted: 08/31/2018] [Indexed: 12/02/2022] Open
Abstract
Objective: This study aimed to investigate the association between cognitive impairment and cerebral haemodynamic changes in patients with chronic vertebra-basilar (VB) stenosis. Methods: Patients with severe posterior circulation VB stenosis and infarction or a history of infarction for more than 2 weeks from January 2014 to January 2015 were enrolled (n = 96). They were divided into three groups, namely, the computed tomography perfusion (CTP) normal group, the CTP compensated group, and the CTP decompensated group. Cognitive function was assessed using a validated Chinese version of the Mini-Mental State Examination (MMSE), the Frontal Assessment Battery (FAB), and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Regression models were used to identify independent risk factors for cognitive impairment. Results: The MMSE and FAB scores of patients in the CTP decompensated group were significantly lower than those of patients in the CTP normal and CTP compensated groups (all p < 0.05). The RBANS total and its domain scores, including immediate memory, visual acuity, and delayed memory, in the CTP compensated and CTP decompensated groups were significantly lower than those in the CTP normal group (all p < 0.05). Multiple regression analyses showed that CTP compensation, CTP decompensation, severe VB tandem stenosis, and multiple infarctions were independent risk factors for cognitive impairment. Conclusions: Low perfusion caused by severe VB stenosis can lead to extensive cognitive impairments in areas such as immediate memory, visual span, and delayed memory.
Collapse
Affiliation(s)
- Yiming Deng
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Luyao Wang
- Intelligent Robotics Institute, School of Mechatronical Engineering, Beijing Institute of Technology, Beijing, China
| | - Xuan Sun
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Lian Liu
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Meifang Zhu
- China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Departments of Neuropsychiatry and Clinical Psychology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Chunxue Wang
- China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Departments of Neuropsychiatry and Clinical Psychology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Binbin Sui
- China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Mi Shen
- China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Weibin Gu
- China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Dapeng Mo
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Ning Ma
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Ligang Song
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Xiaoqing Li
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Xiaochuan Huo
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Zhongrong Miao
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| | - Duanduan Chen
- School of Life Science, Beijing Institute of Technology, Beijing, China.,Key Laboratory of Convergence Medical Engineering System and Healthcare Technology, The Ministry of Industry and Information Technology, Beijing Institute of Technology, Beijing, China
| | - Feng Gao
- Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
| |
Collapse
|
5
|
Zhang C, Wang Y, Zhao X, Liu L, Wang C, Pu Y, Zou X, Pan Y, Wong KS, Wang Y. Prediction of Recurrent Stroke or Transient Ischemic Attack After Noncardiogenic Posterior Circulation Ischemic Stroke. Stroke 2017. [PMID: 28626054 DOI: 10.1161/strokeaha.116.016285] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
BACKGROUND AND PURPOSE Posterior circulation ischemic stroke (IS) is generally considered an illness with a poor prognosis. However, there are no effective rating scales to predict recurrent stroke following it. Therefore, our aim was to identify clinical or radiological measures that could assist in predicting recurrent cerebral ischemic episodes. METHODS We prospectively enrolled 723 noncardiogenic posterior circulation IS patients with onset of symptoms <7 days. Stroke risk factors, admission symptoms and signs, topographical distribution and responsible cerebral artery of acute infarcts, and any recurrent IS or transient ischemic attack (TIA) within 1 year were assessed. Cox regression was used to identify risk factors associated with recurrent IS or TIA within the year after posterior circulation IS. RESULTS A total of 40 patients (5.5%) had recurrent IS or TIA within 1 year of posterior circulation IS. Multivariate Cox regression identified chief complaint with dysphagia (hazard ratio [HR], 4.16; 95% confidence interval [CI], 1.69-10.2; P=0.002), repeated TIAs within 3 months before the stroke (HR, 15.4; 95% CI, 5.55-42.5; P<0.0001), responsible artery stenosis ≥70% (HR, 7.91; 95% CI, 1.00-62.6; P=0.05), multisector infarcts (HR, 5.38; 95% CI, 1.25-23.3; P=0.02), and not on antithrombotics treatment at discharge (HR, 3.06; 95% CI, 1.09-8.58; P=0.03) as independent predictors of recurrent IS or TIA. CONCLUSIONS Some posterior circulation IS patients are at higher risk for recurrent IS or TIA. Urgent assessment and preventive treatment should be offered to these patients as soon as possible.
Collapse
Affiliation(s)
- Changqing Zhang
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Yilong Wang
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Xingquan Zhao
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Liping Liu
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - ChunXue Wang
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Yuehua Pu
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Xinying Zou
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Yuesong Pan
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Ka Sing Wong
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.)
| | - Yongjun Wang
- From the Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, China (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); China National Clinical Research Center for Neurological Diseases, Beijing (C.Z., Yilong Wang, X.Z., L.L., C.W., Y.P., X.Z., Y.P., Yongjun Wang); Center of Stroke, Beijing Institute for Brain Disorders, China (Yongjun Wang); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Yongjun Wang); and Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, China (K.S.W.).
| | | |
Collapse
|
6
|
Petrusic I, Podgorac A, Zidverc-Trajkovic J, Radojicic A, Jovanovic Z, Sternic N. Do interictal microembolic signals play a role in higher cortical dysfunction during migraine aura? Cephalalgia 2015; 36:561-7. [DOI: 10.1177/0333102415607191] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2015] [Accepted: 07/09/2015] [Indexed: 01/03/2023]
Abstract
Introduction The aim of this study was to evaluate the prevalence and clinical impact of interictal microembolic signals (MES) in patients suffering from migraine with higher cortical dysfunction (HCD), such as language and memory impairment, during an aura. Patients and methods This study was carried out on 34 migraineurs with language and memory impairment during aura (HCD group), 31 migraineurs with only visual or visual and somatosensory symptoms during aura (Control group I), and 34 healthy controls (Control group II). We used a Doppler instrument to detect microemboli. Demographic data, disease features and the detection of MES between these groups, as well as the predictors of HCD during the aura, were analyzed. Results The duration of aura was longer and the frequency of aura was higher among patients with language and memory impairment during aura compared to Control group I. MES was detected in 29.4% patients from the HCD group, which was significantly higher compared to 3.2% in Control group I and 5.9% in Control group II. Regarding the absence or presence of MES, demographic and aura features were not different in the HCD subgroups. A longer duration of aura, the presence of somatosensory symptoms during the aura and the presence of interictal MES were independent predictors of HCD during the aura. Conclusion The present findings indicate that HCD and MES are related in patients with migraine with aura. Further research is needed to better understand the exact pathophysiological mechanism.
Collapse
Affiliation(s)
- I Petrusic
- Faculty of Medicine, University of Belgrade, Serbia
- Department of Physiology, Faculty of Pharmacy, University of Belgrade, Serbia
| | - A Podgorac
- Faculty of Medicine, University of Belgrade, Serbia
- Institute of Mental Health, Serbia
| | - J Zidverc-Trajkovic
- Faculty of Medicine, University of Belgrade, Serbia
- Neurology Clinic, Clinical Center of Serbia, Serbia
| | - A Radojicic
- Faculty of Medicine, University of Belgrade, Serbia
- Neurology Clinic, Clinical Center of Serbia, Serbia
| | - Z Jovanovic
- Faculty of Medicine, University of Belgrade, Serbia
- Neurology Clinic, Clinical Center of Serbia, Serbia
| | - N Sternic
- Faculty of Medicine, University of Belgrade, Serbia
- Neurology Clinic, Clinical Center of Serbia, Serbia
| |
Collapse
|